Can C-reactive protein improve treatment for COPD exacerbations?
www.pulmccm.org
Use of C-reactive protein (CRP) in decision-making may reduce antibiotic use in COPD exacerbations, but not as a replacement for clinical judgment, a study suggested. Chronic obstructive pulmonary disease (COPD) exacerbations are characterized by increased inflammation in the airways and the body generally. C-reactive protein (CRP) is a serum test for inflammation, and has been explored as a biomarker to help guide treatment in a variety of conditions sharing inflammation as a feature.
Can C-reactive protein improve treatment for COPD exacerbations?
Can C-reactive protein improve treatment for…
Can C-reactive protein improve treatment for COPD exacerbations?
Use of C-reactive protein (CRP) in decision-making may reduce antibiotic use in COPD exacerbations, but not as a replacement for clinical judgment, a study suggested. Chronic obstructive pulmonary disease (COPD) exacerbations are characterized by increased inflammation in the airways and the body generally. C-reactive protein (CRP) is a serum test for inflammation, and has been explored as a biomarker to help guide treatment in a variety of conditions sharing inflammation as a feature.